Dose-escalated neoadjuvant chemoradiotherapy for locally advanced oesophageal or oesophagogastric junctional adenocarcinoma

BACKGROUND: Neoadjuvant chemoradiotherapy with CROSS-protocol is the standard of care for locally advanced esophageal cancer. The purpose of this study was to demonstrate an improvement in complete pathological response (ypCR) after a dose-escalation neoadjuvant protocol compared to standard treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Duque-Santana, Victor, López-Campos, Fernando, Martin, Margarita, Pelari, Lira, Hernandez, Antonio, Valero, Mireia, Galindo, Julio, Priego, Pablo, Cuadrado, Marta, Longo, Federico, Caminoa-Lizarralde, María, Sancho, Sonsoles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518782/
https://www.ncbi.nlm.nih.gov/pubmed/36186695
http://dx.doi.org/10.5603/RPOR.a2022.0054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518782/
https://www.ncbi.nlm.nih.gov/pubmed/36186695
http://dx.doi.org/10.5603/RPOR.a2022.0054

Ejemplares similares